Patent · US Active

N-acetyl mannosammine as a therapeutic agent

US10335426B2 · kind B2 · utility

0Cited by

3References

9Claims

0Family size

Assignee

The United States of America, as represented by the Secretary, Department of Health and Human Services · US

Inventors

Marjan Huizing · Kensington, US
William A. Gahl · Kensington, US
Irini Manoli · Rockville, US
Enriko Klootwijk · London, GB

Key dates

Filing date	Sep 12, 2017
Grant date	Jul 2, 2019
Priority date	—
Expiry date	Sep 12, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compositions and methods for treating kidney and muscle dysfunction that involves use of therapeutic amounts of N-acetyl mannosamine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.